• Posted On Friday, April 16, 2021 by Evan Lamolinara

    Pharmaq12021

    SalesLeads announced today the Q1 2021 results for the new planned capital project spending report for the Pharmaceutical and BioTech industry. The Firm tracks North American planned industrial capital project activity including facility expansions, new plant construction and significant equipment modernization project. Research confirms 97 new projects in the Pharmaceutical sector.

    Planned industrial project activity within the sector is up 36% YTD over the previous year.

    The following are selected highlights on new Pharmaceutical industry construction news.

     

    Pharmaceutical - By Project Type

                Manufacturing/Processing Facilities - 72 New Projects

                Laboratory Facilities - 23 New Projects

                Distribution and Industrial Warehouse - 13 New Projects

               

    Pharmaceutical - By Project Scope/Activity

                New Construction - 22 New Projects

                Expansion - 33 New Projects

                Renovations/Equipment Upgrades - 46 New Projects

                Plant Closing - 0 New Projects

     

    Pharmaceutical - By Project Location (Top 5 States)

                California - 13

                Massachusetts - 12

                North Carolina - 9

                Tennessee - 6

                Indiana - 6

            

    Largest Planned Project

    During the 1st quarter of 2021, our research team identified 4 new Pharmaceutical facility construction projects with an estimated value of $100 million or more.

    The largest project is owned by Fujifilm Diosynth Biotechnologies, who is planning to invest $1.5 billion for the construction of a processing facility in HOLLY SPRINGS, NC.

     

    Top 5 Tracked Pharmaceutical Projects

    NORTH CAROLINA:

    Biotechnology company is planning to invest $200 million for the construction of a 175,000 sf processing facility in RESEARCH TRIANGLE PARK, NC. Completion is slated for 2023.

     

    MASSACHUSETTS:

    Biotechnology company is investing $150 million for the renovation and equipment upgrades on a 130,000 sf processing facility in BOXBOROUGH, MA. Construction will occur in multiple phases, with completion slated for 2022.

     

    SOUTH CAROLINA:

    Biotechnology company is planning to invest $54 million for an expansion of their processing facility at 535 N. Emerald Rd. in GREENWOOD, SC. Construction will occur in multiple phases, with completion slated for 2025.

     

    BRITISH COLUMBIA:

    Biotechnology company is planning to invest $50 million for the construction of a 40,000 sf processing facility in VANCOUVER, BC. They have recently received approval for the project. Completion is slated for Spring 2023.

     

    CALIFORNIA:

    Biotechnology company is investing $55 million and has recently started an expansion of their processing facility in TUSTIN, CA. Completion is slated for early 2022.

     

    Since 1959, SalesLeads, based out of Jacksonville, FL has been providing Industrial Project Reports on companies that are planning significant capital investments in their industrial facilities throughout North America. Our professional research team identifies new construction, expansion, relocation, major renovation, equipment upgrades, and plant closing project opportunities so that our clients can focus sales and marketing resources on the target accounts that have an impending need for their products, services, and indirect materials.

    Each month, our team provides hundreds of industrial reports within a variety of industries, including:


    Comment